Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4703)
All Articles published online
|
Apr 28, 2007 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Teufel A, Staib F, Kanzler S, Weinmann A, Schulze-Bergkamen H, Galle PR. Genetics of hepatocellular carcinoma. World J Gastroenterol 2007; 13(16): 2271-2282 [PMID: 17511024 DOI: 10.3748/wjg.v13.i16.2271] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i16/2271.htm |
| Number | Citing Articles |
| 1 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 2 |
Andreas Teufel, Jens U. Marquardt, Frank Staib, Peter R. Galle. Snapshot liver transcriptome in hepatocellular carcinoma. Journal of Hepatology 2012; 56(4): 990 doi: 10.1016/j.jhep.2011.08.024
|
| 3 |
Henryk Dudek, Darren H Wong, Rokhand Arvan, Anee Shah, Kathleen Wortham, Bo Ying, Rohan Diwanji, Wei Zhou, Benjamin Holmes, Hailin Yang, Wendy A Cyr, Yi Zhou, Aalok Shah, Ruchir Farkiwala, Michael Lee, Yiting Li, Garrett R Rettig, Michael A Collingwood, Sujit K Basu, Mark A Behlke, Bob D Brown. Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo. Molecular Therapy 2014; 22(1): 92 doi: 10.1038/mt.2013.233
|
| 4 |
Polina Iakova, Lubov Timchenko, Nikolai A. Timchenko. Intracellular signaling and hepatocellular carcinoma. Seminars in Cancer Biology 2011; 21(1): 28 doi: 10.1016/j.semcancer.2010.09.001
|
| 5 |
Irena Ivanovska, Chunsheng Zhang, Angela M. Liu, Kwong F. Wong, Nikki P. Lee, Patrick Lewis, Ulrike Philippar, Dimple Bansal, Carolyn Buser, Martin Scott, Mao Mao, Ronnie T. P. Poon, Sheung Tat Fan, Michele A. Cleary, John M. Luk, Hongyue Dai, Wanjin Hong. Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma. PLoS ONE 2011; 6(9): e24582 doi: 10.1371/journal.pone.0024582
|
| 6 |
Feng Zhong, Xinsheng Cheng, Shibo Sun, Jie Zhou. Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells. Oncology Reports 2017; 37(5): 3061 doi: 10.3892/or.2017.5523
|
| 7 |
Lars Zender, Scott W. Lowe. Molecular Genetics of Liver Neoplasia. 2010; : 189 doi: 10.1007/978-1-4419-6082-5_10
|
| 8 |
J. M. Cullen, C. Williams, L. Zadrozny, J. T. Otstot, G. G. Solomon, R. C. Sills, H-H. L. Hong. H-ras Consensus Sequence and Mutations in Primary Hepatocellular Carcinomas of Lemurs and Lorises. Veterinary Pathology 2011; 48(4): 868 doi: 10.1177/0300985810388526
|
| 9 |
Philippe Couvert, Alain Carrié, Jacques Pariès, Jenny Vaysse, Audrey Miroglio, Antoine Kerjean, Pierre Nahon, Jamel Chelly, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne-Carrié. Liver <italic>insulin-like growth factor 2</italic> methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(35): 5419-5427 doi: 10.3748/wjg.14.5419
|
| 10 |
Diego F. Calvisi, Federico Pinna, Rossella Pellegrino, Valeria Sanna, Marcella Sini, Lucia Daino, Maria M. Simile, Maria R. De Miglio, Maddalena Frau, Maria L. Tomasi, Maria A. Seddaiu, Maria R. Muroni, Francesco Feo, Rosa M. Pascale. Ras‐driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control. International Journal of Cancer 2008; 123(9): 2057 doi: 10.1002/ijc.23720
|
| 11 |
Alev Deli, Emanuel Kreidl, Stefan Santifaller, Barbara Trotter, Katja Seir, Walter Berger, Rolf Schulte-Hermann, Chantal Rodgarkia-Dara, Michael Grusch. Activins and activin antagonists in hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1699-1709 doi: 10.3748/wjg.14.1699
|
| 12 |
L G Alexopoulos, I N Melas, A D Chairakaki, J Saez-Rodriguez, A Mitsos. Construction of signaling pathways and identification of drug effects on the liver cancer cell HepG2. 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology 2010; : 6717 doi: 10.1109/IEMBS.2010.5626246
|
| 13 |
Yi Fang, Youjun Feng, Tongjin Wu, Swaminath Srinivas, Weiqiang Yang, Jue Fan, Chi Yang, Shihua Wang, Masaru Katoh. Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a. PLoS ONE 2013; 8(8): e73004 doi: 10.1371/journal.pone.0073004
|
| 14 |
Shu-Huan Wu, Charng-Cherng Chyau, Jing-Hsien Chen, Shu-Fen Tu, Hui-Hsuan Lin, Fen-Pi Chou. Anti-cancerous effects of Wasabia japonica extract in Hep3B liver cancer cells via ROS accumulation, DNA damage and p73-mediated apoptosis. Journal of Functional Foods 2015; 14: 445 doi: 10.1016/j.jff.2014.12.032
|
| 15 |
Lisa H. Apken, Andrea Oeckinghaus. Signal Transduction in Cancer and Immunity. International Review of Cell and Molecular Biology 2021; 361: 21 doi: 10.1016/bs.ircmb.2020.10.005
|
| 16 |
Li Liang, Jian Guan, Yuanfeng Zeng, Jianmei Wang, Xianzheng Li, Xiaojing Zhang, Yanqing Ding. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma. Human Pathology 2011; 42(11): 1603 doi: 10.1016/j.humpath.2010.08.025
|
| 17 |
Andreas Teufel, Jens U. Marquardt, Peter R. Galle. Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt/β-catenin. Journal of Hepatology 2013; 58(3): 622 doi: 10.1016/j.jhep.2012.10.006
|
| 18 |
Andreas Teufel, Thorsten Maass, Susanne Strand, Stephan Kanzler, Tiziana Galante, Kevin Becker, Dennis Strand, Stefan Biesterfeld, Heiner Westphal, Peter R. Galle. Liver-specific Ldb1 deletion results in enhanced liver cancer development. Journal of Hepatology 2010; 53(6): 1078 doi: 10.1016/j.jhep.2010.05.027
|
| 19 |
Leonidas G. Alexopoulos, Douglas A. Lauffenburger, Peter K. Sorger. Modeling pro-death signaling pathways in cancer hepatocytes using multi-combinatorial treatments of inhibitors and stimuli. 2008 8th IEEE International Conference on BioInformatics and BioEngineering 2008; : 1 doi: 10.1109/BIBE.2008.4696732
|
| 20 |
Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, Lewis R Roberts. Treatment options for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2008; 2(1): 81 doi: 10.1586/17474124.2.1.81
|
| 21 |
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang. Genetic alterations in hepatocellular carcinoma: An update. World Journal of Gastroenterology 2016; 22(41): 9069-9095 doi: 10.3748/wjg.v22.i41.9069
|
| 22 |
Franziska van Zijl, Gudrun Zulehner, Michaela Petz, Doris Schneller, Christoph Kornauth, Mara Hau, Georg Machat, Markus Grubinger, Heidemarie Huber, Wolfgang Mikulits. Epithelial–mesenchymal transition in hepatocellular carcinoma. Future Oncology 2009; 5(8): 1169 doi: 10.2217/fon.09.91
|
| 23 |
Susan Fanayan, Joshua T. Smith, Ling Y. Lee, Fangfei Yan, Michael Snyder, William S. Hancock, Edouard Nice. Proteogenomic Analysis of Human Colon Carcinoma Cell Lines LIM1215, LIM1899, and LIM2405. Journal of Proteome Research 2013; 12(4): 1732 doi: 10.1021/pr3010869
|
| 24 |
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, Luisa Rendón-Garlant, Patricia Nefertari Ramírez-Flores, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Ethel Daniela Cabello-Ruiz, Fabiola Castorena-Torres, Mario Bermúdez de León. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(3): 1760 doi: 10.3390/ijms25031760
|
| 25 |
T. Schneider-Merck, I. Borbath, N. Charette, C. De Saeger, J. Abarca, I. Leclercq, Y. Horsmans, P. Stärkel. The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats. European Journal of Cancer 2009; 45(11): 2050 doi: 10.1016/j.ejca.2009.04.014
|
| 26 |
Masamichi Nakayama, Sachiko Ogasawara, Jun Akiba, Kosuke Ueda, Keiko Koura, Keita Todoroki, Hisafumi Kinoshita, Hirohisa Yano. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells. Journal of Gastroenterology and Hepatology 2014; 29(5): 1092 doi: 10.1111/jgh.12484
|
| 27 |
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 2023; 12(2): 188 doi: 10.3390/biology12020188
|
| 28 |
Thorsten Maass, Jens Marquardt, Ju-Seog Lee, Markus Krupp, Peter Scholz-Kreisel, Carolin Mogler, Peter Schirmacher, Martina Müller, Heiner Westphal, Peter R. Galle, Andreas Teufel. Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice. Oncotarget 2016; 7(20): 28903 doi: 10.18632/oncotarget.3293
|
| 29 |
Timo Itzel, Rainer Spang, Thorsten Maass, Stefan Munker, Stephanie Roessler, Matthias P. Ebert, Hans J. Schlitt, Wolfgang Herr, Matthias Evert, Andreas Teufel. Random gene sets in predicting survival of patients with hepatocellular carcinoma. Journal of Molecular Medicine 2019; 97(6): 879 doi: 10.1007/s00109-019-01764-2
|
| 30 |
Yih‐Horng Shiao. Genetic signature for human risk assessment: Lessons from trichloroethylene. Environmental and Molecular Mutagenesis 2009; 50(1): 68 doi: 10.1002/em.20432
|
| 31 |
Ludovica Segat, Michele Milanese, Doroti Pirulli, Chiara Trevisiol, Francesco Lupo, Mauro Salizzoni, Antonio Amoroso, Sergio Crovella. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients. Journal of Gastroenterology and Hepatology 2009; 24(12): 1840 doi: 10.1111/j.1440-1746.2009.06009.x
|
| 32 |
Ramadhan B. Matondo, Mathilda J.M. Toussaint, Klaas M. Govaert, Luciel D. van Vuuren, Sathidpak Nantasanti, Maarten W. Nijkamp, Shusil K. Pandit, Peter C.J. Tooten, Mirjam H. Koster, Kaylee Holleman, Arend Schot, Guoqiang Gu, Bart Spee, Tania Roskams, Inne Borel Rinkes, Baukje Schotanus, Onno Kranenburg, Alain de Bruin. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb. Oncotarget 2016; 7(34): 54662 doi: 10.18632/oncotarget.9952
|
| 33 |
Andreas Teufel, Jean François Dufour. Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma. Gastroenterology 2016; 151(2): 231 doi: 10.1053/j.gastro.2016.06.034
|
| 34 |
Thorsten Maass, Florian R. Thieringer, Amrit Mann, Thomas Longerich, Peter Schirmacher, Dennis Strand, Torsten Hansen, Peter R. Galle, Andreas Teufel, Stephan Kanzler. Liver specific overexpression of platelet‐derived growth factor‐B accelerates liver cancer development in chemically induced liver carcinogenesis. International Journal of Cancer 2011; 128(6): 1259 doi: 10.1002/ijc.25469
|
| 35 |
P. R. Galle. Liver under Constant Attack — From Fat to Viruses. 2009; : 58 doi: 10.1007/978-90-481-2759-7_8
|
| 36 |
Peter R. Galle. Sorafenib in advanced hepatocellular carcinoma – We have won a battle not the war. Journal of Hepatology 2008; 49(5): 871 doi: 10.1016/j.jhep.2008.09.001
|
| 37 |
Bo Wang, Keisuke Hikosaka, Nishat Sultana, Mohammad Tofael Kabir Sharkar, Hidenao Noritake, Wataru Kimura, Yi-Xin Wu, Yoshimasa Kobayashi, Tadayoshi Uezato, Naoyuki Miura. Liver tumor formation by a mutant retinoblastoma protein in the transgenic mice is caused by an upregulation of c-Myc target genes. Biochemical and Biophysical Research Communications 2012; 417(1): 601 doi: 10.1016/j.bbrc.2011.12.014
|
| 38 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
|
| 39 |
Massimo Roncalli, Luca Di Tommaso, Mauro Borzio, Young Nyun Park. Practical Hepatic Pathology: A Diagnostic Approach. 2011; : 457 doi: 10.1016/B978-0-443-06803-4.00033-2
|
| 40 |
Sathidpak Nantasanti, Mathilda J. M. Toussaint, Sameh A. Youssef, Peter C. J. Tooten, Alain de Bruin, Matias A Avila. Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression. PLOS ONE 2016; 11(3): e0150064 doi: 10.1371/journal.pone.0150064
|
| 41 |
Rim Serhal, Nagib Saliba, George Hilal, Mayssam Moussa, Ghada S Hassan, Oula El Atat, Nada Alaaeddine. Effect of adipose-derived mesenchymal stem cells on hepatocellular carcinoma: <i>In vitro</i> inhibition of carcinogenesis. World Journal of Gastroenterology 2019; 25(5): 567-583 doi: 10.3748/wjg.v25.i5.567
|
| 42 |
Indranil Banerjee, Paul B. Fisher, Devanand Sarkar. . Advances in Cancer Research 2021; 152: 329 doi: 10.1016/bs.acr.2021.05.003
|
| 43 |
Zain Ul Abedien, Kainat Gul, Sara Khan, Maheen Shafiq, Khizar Rahman, Muhammad Hassan Nawaz. Pathogenesis of Oncoviruses: A Systemic Review. Microbiology and Biotechnology Letters 2023; 51(2): 135 doi: 10.48022/mbl.2303.03006
|
| 44 |
Eric T. Sawey, Maia Chanrion, Chunlin Cai, Guanming Wu, Jianping Zhang, Lars Zender, Alice Zhao, Ronald W. Busuttil, Herman Yee, Lincoln Stein, Dorothy M. French, Richard S. Finn, Scott W. Lowe, Scott Powers. Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening. Cancer Cell 2011; 19(3): 347 doi: 10.1016/j.ccr.2011.01.040
|
| 45 |
Xia Cong, Cuihua Lu, Xiaodong Huang, Dunpeng Yang, Xiaopeng Cui, Jing Cai, Liting Lv, Song He, Yixin Zhang, Runzhou Ni. Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell proliferation. Human Pathology 2014; 45(7): 1370 doi: 10.1016/j.humpath.2013.11.021
|
| 46 |
Devanand Sarkar. AEG-1/MTDH/LYRIC Implicated in Multiple Human Cancers. Advances in Cancer Research 2013; 120: 193 doi: 10.1016/B978-0-12-401676-7.00007-3
|
| 47 |
Yu‐Hung Su, Kwai‐Fong Ng, Ming‐Chin Yu, Ting‐Jung Wu, Ta‐Sen Yeh, Wei‐Chen Lee, Yong‐Shiang Lin, Tsung‐Han Hsieh, Chun‐Yen Lin, Chau‐Ting Yeh, Tse‐Ching Chen. Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas. Journal of Gastroenterology and Hepatology 2015; 30(9): 1397 doi: 10.1111/jgh.12944
|
| 48 |
Margaret A. Park, Guo Zhang, Clint Mitchell, Mohamed Rahmani, Hossein Hamed, Michael P. Hagan, Adly Yacoub, David T. Curiel, Paul B. Fisher, Steven Grant, Paul Dent. Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. Molecular Cancer Therapeutics 2008; 7(9): 2633 doi: 10.1158/1535-7163.MCT-08-0400
|
| 49 |
HYUN JUNG KIM, SONG YI PARK, HYE MIN LEE, DONG IK SEO, YOUNG-MIN KIM. Antiproliferative effect of the methanol extract from the roots of Petasites japonicus on Hep3B hepatocellular carcinoma cells in vitro and in vivo. Experimental and Therapeutic Medicine 2015; 9(5): 1791 doi: 10.3892/etm.2015.2296
|
| 50 |
Mi-Kyung Song, Yong-Keun Park, Jae-Chun Ryu. Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK. Toxicology and Applied Pharmacology 2013; 273(1): 130 doi: 10.1016/j.taap.2013.08.016
|
| 51 |
Iman A. Abdelgawad, Noha H. Radwan, Hala R. Hassanein. KIAA0101 mRNA expression in the peripheral blood of hepatocellular carcinoma patients: Association with some clinicopathological features. Clinical Biochemistry 2016; 49(10-11): 787 doi: 10.1016/j.clinbiochem.2015.12.016
|
| 52 |
Ella F Gunady, Kathryn E Ware, Sarah Hoskinson Plumlee, Nicolas Devos, David Corcoran, Joseph Prinz, Hrvoje Misetic, Francesca D Ciccarelli, Tara M Harrison, Jeffrey L Thorne, Robert Schopler, Jeffrey I Everitt, William C Eward, Jason A Somarelli. Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers. Evolution, Medicine, and Public Health 2022; 10(1): 221 doi: 10.1093/emph/eoac016
|
| 53 |
Yi-Jung Ho, Yueh-Min Lin, Yen-Chi Huang, Kun-Tu Yeh, Liang-In Lin, Jeng-Wei Lu. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker. Acta Histochemica 2016; 118(1): 38 doi: 10.1016/j.acthis.2015.11.005
|
| 54 |
Peng Zhou, Wei Jiang, Lielin Wu, Ruimin Chang, Kemin Wu, Zhiming Wang. miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma. Digestive Diseases and Sciences 2012; 57(5): 1171 doi: 10.1007/s10620-012-2099-2
|
| 55 |
Byoung Kwon Yoo, Luni Emdad, Zao-zhong Su, Augusto Villanueva, Derek Y. Chiang, Nitai D. Mukhopadhyay, Alan Scott Mills, Samuel Waxman, Robert A. Fisher, Josep M. Llovet, Paul B. Fisher, Devanand Sarkar. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. Journal of Clinical Investigation 2009; 119(3): 465 doi: 10.1172/JCI36460
|
| 56 |
Cecilia Scisciani, Stefania Vossio, Francesca Guerrieri, Valeria Schinzari, Rossana De Iaco, Paolo D’Onorio de Meo, Melchiorre Cervello, Giuseppe Montalto, Teresa Pollicino, Giovanni Raimondo, Massimo Levrero, Natalia Pediconi. Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. Journal of Hepatology 2012; 56(4): 855 doi: 10.1016/j.jhep.2011.11.017
|
| 57 |
Po-Shuan Huang, Chia-Jung Liao, Ya-Hui Huang, Chau-Ting Yeh, Cheng-Yi Chen, Hui-Chi Tang, Cheng-Chih Chang, Kwang-Huei Lin. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers 2021; 13(21): 5361 doi: 10.3390/cancers13215361
|
| 58 |
Suzan Abdu, Nouf Juaid, Amr Amin, Mohamed Moulay, Nabil Miled. Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights. Antioxidants 2022; 11(9): 1645 doi: 10.3390/antiox11091645
|
| 59 |
T. Clark Gamblin, Sydney D. Finkelstein, J. Wallis Marsh. Hepatocellular Carcinoma. 2009; : 467 doi: 10.1007/978-1-60327-376-3_18
|
| 60 |
Diego F. Calvisi, Maria M. Simile, Sara Ladu, Maddalena Frau, Matthias Evert, Maria L. Tomasi, Maria I. Demartis, Lucia Daino, Maria A. Seddaiu, Stefania Brozzetti, Francesco Feo, Rosa M. Pascale. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. Hepatology 2011; 53(4): 1226 doi: 10.1002/hep.24174
|
| 61 |
Erika Ramos‐Tovar, Pablo Muriel. Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage. Journal of Applied Toxicology 2020; 40(1): 151 doi: 10.1002/jat.3880
|
| 62 |
Lars Zender, Wen Xue, Johannes Zuber, Camile P. Semighini, Alexander Krasnitz, Beicong Ma, Peggy Zender, Stefan Kubicka, John M. Luk, Peter Schirmacher, W. Richard McCombie, Michael Wigler, James Hicks, Gregory J. Hannon, Scott Powers, Scott W. Lowe. An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer. Cell 2008; 135(5): 852 doi: 10.1016/j.cell.2008.09.061
|
| 63 |
Shugo Suzuki, Kentaro Takeshita, Makoto Asamoto, Satoru Takahashi, Hitoshi Kandori, Kazunari Tsujimura, Fumiyo Saito, Kazuo Masuko, Tomoyuki Shirai. High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans. Toxicology 2009; 255(3): 160 doi: 10.1016/j.tox.2008.10.023
|
| 64 |
Fidel D. Huitzil‐Melendez, Ghassan K. Abou‐Alfa, Michael A. Morse. Malignant Liver Tumors. 2010; : 382 doi: 10.1002/9781444317053.ch32
|
| 65 |
Xue Pang, Wei Wan, Xingxing Wu, Yu Shen, Ferenc Olasz. The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. International Journal of Genomics 2022; 2022: 1 doi: 10.1155/2022/8755263
|
| 66 |
Mudassier Ahmad, Anupam Dhasmana, Prateek Suresh Harne, Asif Zamir, Bilal Bin Hafeez. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?. Seminars in Cancer Biology 2022; 86: 1175 doi: 10.1016/j.semcancer.2022.02.015
|
| 67 |
Weiwei Guo, Lichong Yan, Ling Yang, Xiaoyu Liu, Qiukai E, Peiye Gao, Xiaofei Ye, Wen Liu, Ji Zuo, Yuan-Soon Ho. Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma. PLoS ONE 2014; 9(1): e85766 doi: 10.1371/journal.pone.0085766
|
| 68 |
Rosa M. Pascale, M. Frau, Francesco Feo. Nitric Oxide (NO) and Cancer. 2010; : 309 doi: 10.1007/978-1-4419-1432-3_17
|
| 69 |
Alexandra W. Acher, Amir A. Rahnemai-Azar, Sharon M. Weber, Timothy M. Pawlik. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 31 doi: 10.1007/978-981-19-0063-1_5
|
| 70 |
|
| 71 |
Emmanuelle Berger, Nathalie Vega, Hubert Vidal, Alain Geloën. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival. Biotechnology Journal 2012; 7(11): 1395 doi: 10.1002/biot.201200188
|
| 72 |
Mohamad Ezzeldin, Emma Borrego-Diaz, Mohammad Taha, Tuba Esfandyari, Amanda L. Wise, Warner Peng, Alex Rouyanian, Atabak Asvadi Kermani, Mina Soleimani, Elham Patrad, Kristina Lialyte, Kun Wang, Stephen Williamson, Bashar Abdulkarim, Mojtaba Olyaee, Faris Farassati. RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC). Molecular Oncology 2014; 8(5): 1043 doi: 10.1016/j.molonc.2014.03.020
|
| 73 |
Li Liu, Shuang Zhang, Lei Hu, Linhua Liu, Wuhua Guo, Jixiang Zhang. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway. Molecular Medicine Reports 2017; 16(6): 9287 doi: 10.3892/mmr.2017.7820
|
| 74 |
Quoc V Tu, Arinze S Okoli, Zsuzsanna Kovach, George L Mendz. Hepatocellular carcinoma: prevalence and molecular pathogenesis ofHelicobacterspp.. Future Microbiology 2009; 4(10): 1283 doi: 10.2217/fmb.09.90
|
| 75 |
Tian Yang, Bin Song, Jin Zhang, Guang-Shun Yang, Han Zhang, Wei-Feng Yu, Meng-Chao Wu, Jun-Hua Lu, Feng Shen. STK33 promotes hepatocellular carcinoma through binding to c-Myc. Gut 2016; 65(1): 124 doi: 10.1136/gutjnl-2014-307545
|
| 76 |
Jian Yao, Linhui Liang, Shenglin Huang, Jie Ding, Ning Tan, Yingjun Zhao, Mingxia Yan, Chao Ge, Zhenfeng Zhang, Taoyang Chen, Dafang Wan, Ming Yao, Jinjun Li, Jianren Gu, Xianghuo He. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; : NA doi: 10.1002/hep.23443
|
| 77 |
Edmund Kwok-Kwan Tung, Betty Yin-Chi Wong, Tai-On Yau, Irene Oi-Lin Ng, Surinder K. Batra. Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion. PLoS ONE 2012; 7(5): e36565 doi: 10.1371/journal.pone.0036565
|
| 78 |
A. Kathleen McClendon, Jeffry L. Dean, Adam Ertel, Zhiyan Fu, Dayana B. Rivadeneira, Christopher A. Reed, Ryan J. Bourgo, Agnieszka Witkiewicz, Sankar Addya, Christopher N. Mayhew, H. Leighton Grimes, Paolo Fortina, Erik S. Knudsen. RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage. Gastroenterology 2011; 141(4): 1439 doi: 10.1053/j.gastro.2011.06.046
|
| 79 |
Yi‐Jen Liao, Shih‐Ping Liu, Cheng‐Ming Lee, Chia‐Hung Yen, Pei‐Chun Chuang, Chia‐Yen Chen, Ting‐Fen Tsai, Shiu‐Feng Huang, Yan‐Hwa Wu Lee, Yi‐Ming Arthur Chen. Characterization of a glycine N‐methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. International Journal of Cancer 2009; 124(4): 816 doi: 10.1002/ijc.23979
|
| 80 |
Shuning He, SF Gabby Krens, Huiqing Zhan, Zhiyuan Gong, Pancras CW Hogendoorn, Herman P Spaink, B Ewa Snaar‐Jagalska. A ΔRaf1–ER‐inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures. The Journal of Pathology 2011; 225(1): 19 doi: 10.1002/path.2936
|
| 81 |
Jihye Choi, Sae Bom Won, Young Hye Kwon. Maternal Consumption of a Low-Isoflavone Soy Protein Isolate Diet Accelerates Chemically Induced Hepatic Carcinogenesis in Male Rat Offspring. Nutrients 2020; 12(2): 571 doi: 10.3390/nu12020571
|
| 82 |
M Colombino, P Sperlongano, F Izzo, F Tatangelo, G Botti, A Lombardi, M Accardo, L Tarantino, I Sordelli, M Agresti, A Abbruzzese, M Caraglia, G Palmieri. BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death & Disease 2012; 3(1): e259 doi: 10.1038/cddis.2011.136
|
| 83 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
| 84 |
Li Qu, Hui Chen, Guoliang Wang, Jianfeng Wei. Frequent Losses of Heterozygosity in the Mitofusin 2 Gene in Hepatocellular Carcinoma: Their Relationship to Clinicopathological Features. Tumori Journal 2013; 99(6): 697 doi: 10.1177/030089161309900609
|
| 85 |
Samar Kamal Darweesh, Rasha Ahmed Abd Alziz, Heba Omar, Dina Sabry, Wael Fathy. Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 2019; 34(8): 1424 doi: 10.1111/jgh.14541
|
| 86 |
Tetsu Tomonari, Shunsaku Takeishi, Tatsuya Taniguchi, Takahiro Tanaka, Hironori Tanaka, Shota Fujimoto, Tetsuo Kimura, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Tetsuji Takayama. MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma. Oncotarget 2016; 7(6): 7207 doi: 10.18632/oncotarget.6889
|
| 87 |
Lin Wei, Baofeng Lian, Yuannv Zhang, Wei Li, Jianren Gu, Xianghuo He, Lu Xie. Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. BMC Genomics 2014; 15(S1) doi: 10.1186/1471-2164-15-S1-S13
|
| 88 |
John Carson Allen, Jean-Charles Nault, Guili Zhu, Andrew Yu Keat Khor, Jin Liu, Tony Kiat Hon Lim, Jessica Zucman-Rossi, Pierce K.H. Chow. The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population. Medicine 2016; 95(47): e5263 doi: 10.1097/MD.0000000000005263
|
| 89 |
Zengyuan Zhou, Yuzheng Li, Haiyue Hao, Yuanyuan Wang, Zihao Zhou, Zhipeng Wang, Xia Chu. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Cell Transplantation 2019; 28(1_suppl): 76S doi: 10.1177/0963689719893950
|
| 90 |
Shu-Hui Lin, Chung-Min Yeh, Ming-Ju Hsieh, Yueh-Min Lin, Mei-Wen Chen, Chih-Jung Chen, Cheng-Yu Lin, Hsiao-Fang Hung, Kun-Tu Yeh, Shun-Fa Yang. Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma. Tumor Biology 2016; 37(3): 3997 doi: 10.1007/s13277-015-4225-1
|
| 91 |
Leonidas G. Alexopoulos, Julio Saez‐Rodriguez, Christopher W. Espelin. Drug Efficacy, Safety, and Biologics Discovery. 2008; : 29 doi: 10.1002/9780470431818.ch2
|
| 92 |
Peng Zhou, Zhi Chen, Rui-Min Chang, Wei Jiang, Lie-Lin Wu, Zhi-Ming Wang. Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma. Medical Oncology 2012; 29(5): 3063 doi: 10.1007/s12032-012-0258-0
|
| 93 |
Hongyang Wang, Yaqin He, Wen Yang. Primary Liver Cancer. 2012; : 179 doi: 10.1007/978-3-642-28702-2_6
|
| 94 |
Kerstin Herzer, Guido Gerken, Thomas G Hofmann. Hepatitis C-associated liver carcinogenesis: Role of PML nuclear bodies. World Journal of Gastroenterology 2014; 20(35): 12367-12371 doi: 10.3748/wjg.v20.i35.12367
|
| 95 |
Cédric Coulouarn, Snorri S. Thorgeirsson. Molecular Genetics of Liver Neoplasia. 2010; : 221 doi: 10.1007/978-1-4419-6082-5_12
|
| 96 |
Stefan Buchkremer, Jasmin Hendel, Markus Krupp, Arndt Weinmann, Kai Schlamp, Thorsten Maass, Frank Staib, Peter R Galle, Andreas Teufel. Library of molecular associations: curating the complex molecular basis of liver diseases. BMC Genomics 2010; 11(1) doi: 10.1186/1471-2164-11-189
|
| 97 |
Chiara Braconi, Nicola Valeri, Takayuki Kogure, Pierluigi Gasparini, Nianyuan Huang, Gerard J. Nuovo, Luigi Terracciano, Carlo M. Croce, Tushar Patel. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proceedings of the National Academy of Sciences 2011; 108(2): 786 doi: 10.1073/pnas.1011098108
|
| 98 |
Hai-Qing Ma, Xiao-Ting Liang, Jing-Jing Zhao, Hui Wang, Jian-Cong Sun, Yi-Bing Chen, Ke Pan, Jian-Chuan Xia. Decreased expression of <italic>Neurensin-2</italic> correlates with poor prognosis in hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(38): 4844-4848 doi: 10.3748/wjg.15.4844
|
| 99 |
Manal M. Hassan, Donghui Li, Younghun Han, Jinyoung Byun, Rikita I. Hatia, Erping Long, Jiyeon Choi, Robin Kate Kelley, Sean P. Cleary, Anna S. Lok, Paige Bracci, Jennifer B. Permuth, Roxana Bucur, Jian-Min Yuan, Amit G. Singal, Prasun K. Jalal, R. Mark Ghobrial, Regina M. Santella, Yuko Kono, Dimpy P. Shah, Mindie H. Nguyen, Geoffrey Liu, Neehar D. Parikh, Richard Kim, Hui-Chen Wu, Hashem El-Serag, Ping Chang, Yanan Li, Yun Shin Chun, Sunyoung S. Lee, Jian Gu, Ernest Hawk, Ryan Sun, Chad Huff, Asif Rashid, Hesham M. Amin, Laura Beretta, Robert A. Wolff, Samuel O. Antwi, Yehuda Patt, Lu-Yu Hwang, Alison P. Klein, Karen Zhang, Mikayla A. Schmidt, Donna L. White, John A. Goss, Saira A. Khaderi, Jorge A. Marrero, Francisco G. Cigarroa, Pankil K. Shah, Ahmed O. Kaseb, Lewis R. Roberts, Christopher I. Amos. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology 2024; doi: 10.1097/HEP.0000000000000800
|